About SPLENZ PHARMACEUTICALS PRIVATE LIMITED
SPLENZ PHARMACEUTICALS PRIVATE LIMITED is a Private Limited Company and was incorporated on May 27, 2014 in India. It is registered at Registrar of Companies, ROC Pune. Its registered address is S. No. 1095, Milkat. No. 3672, Near Sakal Press, Trimurti Nagar, Wadki, Pune, Pune, Maharashtra, India, 412308. Its corporate identification number is (CIN) U52599PN2014PTC151314 and its current status is Active. Its industry classification as per MCA is other Non-Store Retail Sale N.E.C. (Includes Retail Sale Of Any Kind Of Product In Any Way Which Is Not Included In The Previous Classes/Sub-Classes, Such As By Salespersons Who Go From House To House Or By Vending Machines Or On A Fee Or Contract Basis).
SPLENZ PHARMACEUTICALS PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2024 as per records from Ministry of Corporate Affairs (MCA). SPLENZ PHARMACEUTICALS PRIVATE LIMITED's authorised share capital is ₹20L and its paid up capital is ₹20L. The current board of directors of SPLENZ PHARMACEUTICALS PRIVATE LIMITED comprises Ashish Bhagwan Bhagat and Jitendra Ashok Fasate.
SPLENZ PHARMACEUTICALS PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025.
Key Metrics
CIN
U52599PN2014PTC151314
Location
Current Status
Active
Entity Type
Private Limited Company
Date Of Incorporation
May 27, 2014
Company Age
12 Years 1 Month
Registrar of Companies
ROC - Pune
Last AGM Date
Sep 30, 2024
Latest Revenue
0 - ₹10 Cr as on Mar 31, 2025
Authorized Capital
₹20L
Paid Up Capital
₹20L
Contact Details for SPLENZ PHARMACEUTICALS PRIVATE LIMITED
- *****@splenzpharma.com
- Registered Address
- S. No. 1095, Milkat. No. 3672, Near Sakal Press, Trimurti Nagar, Wadki, Pune, Pune, Maharashtra, India, 412308
Principal Business Activity of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
The majority of SPLENZ PHARMACEUTICALS PRIVATE LIMITED's turnover comes from Manufacturing.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | qgs |
Documents of SPLENZ PHARMACEUTICALS PRIVATE LIMITEDFY 25 Available15 mins
15 minsFiling Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form AOC-4 | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
List of share holders, debenture holders | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
e-Director’s Report | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Optional attachment(s) - if any | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents) | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Optional attachment(s) - if any | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins
Financials of SPLENZ PHARMACEUTICALS PRIVATE LIMITEDFY 25 Available15 mins
SPLENZ PHARMACEUTICALS PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of SPLENZ PHARMACEUTICALS PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 3% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5825 | 3054 | 6179 | 3096 | 5973 |
Total Sales | 1059 | 9365 | 1240 | 7591 | 5488 |
Total Expenses | 4032 | 6764 | 9406 | 4238 | 2925 |
Operating Expenses | 6644 | 7463 | 1374 | 9669 | 3015 |
Employee Expenses | 9714 | 6444 | 2396 | 3634 | 3779 |
Operating Income (EBIT) | 7649 | 9301 | 7628 | 6651 | 2939 |
Interest Expenses | 9313 | 8896 | 6592 | 8154 | 9272 |
Expenses from other activities | 6323 | 1004 | 9222 | 6296 | 9440 |
EBITDA | 7226 | 6586 | 7363 | 7845 | 5141 |
Taxes | 1865 | 4388 | 8383 | 2726 | 6540 |
Net Profit | 3391 | 3875 | 9715 | 1707 | 8861 |
Balance Sheet | |||||
Assets | 2955 | 7048 | 5265 | 2664 | 5824 |
Accounts Receivables | 3513 | 5146 | 7241 | 2252 | 3402 |
Inventory | 5410 | 3769 | 6189 | 6148 | 2501 |
Liabilities | 3840 | 4746 | 7154 | 8041 | 8955 |
Total Debt | 6886 | 3432 | 6501 | 8923 | 9930 |
Accounts Payable | 7872 | 3512 | 3900 | 2605 | 8525 |
Equities | 6381 | 1202 | 7900 | 2620 | 4198 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 5927 | 5189 | 3450 | 4340 | 5132 |
EBIT Margin | 6997 | 6274 | 5302 | 1584 | 3845 |
Net Profit Margin | 3192 | 9401 | 9502 | 7063 | 5042 |
Return on Assets (ROA) | 9297 | 3486 | 4711 | 5583 | 5884 |
Return on Equity (ROE) | 9401 | 6335 | 5241 | 1533 | 2078 |
Return on Capital Employed | 4838 | 3997 | 3449 | 9044 | 8325 |
Return on Invested Capital | 2670 | 2232 | 5986 | 7494 | 6791 |
Efficiency Ratios | |||||
Asset Turnover | 5040 | 4678 | 2474 | 6156 | 8498 |
Receivables Turnover | 1862 | 7647 | 5883 | 1095 | 3189 |
Days Sales Outstanding | 3881 | 8366 | 5412 | 8303 | 4355 |
Inventory Turnover | 6891 | 2453 | 6702 | 9617 | 1762 |
Days Inventory Outstanding | 5235 | 6494 | 5068 | 8927 | 5067 |
Payables Turnover | 2123 | 9903 | 9967 | 6651 | 8731 |
Days Payables Outstanding | 9593 | 5032 | 2755 | 8534 | 7403 |
Liquidity Ratios | |||||
Current Ratio | 2663 | 2656 | 3291 | 1130 | 2447 |
Quick Ratio | 5005 | 3649 | 3432 | 7599 | 9131 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 3108 | 3290 | 2394 | 8643 | 9882 |
Debt Ratio | 3770 | 1439 | 2762 | 6381 | 7664 |
Interest Coverage Ratio | 3642 | 7577 | 4263 | 2061 | 8611 |
Debt Service Coverage Ratio | 2891 | 7121 | 9802 | 4541 | 6529 |
Net Debt/EBITDA | 5372 | 6752 | 8578 | 7630 | 9054 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 2027 | 1263 | 2909 | 5212 | 4670 |
Earnings Growth Rate (CAGR) | 9879 | 3140 | 1373 | 2526 | 6342 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 3% |
3 Year | 843 |
5 Year | 770 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 107% |
3 Year | 749 |
5 Year | 815 |
MSME Payment Delays by SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Loans and Charges on SPLENZ PHARMACEUTICALS PRIVATE LIMITED
SPLENZ PHARMACEUTICALS PRIVATE LIMITED
has taken 2 loans.
Here is a list of loans and charges on SPLENZ PHARMACEUTICALS PRIVATE LIMITED:
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100318836 | ₹59.9L | tqelp{c | Jan 03, 2020 | pcwjqdi | |
10535157 | - | ₹50L | daluhuf | Dec 06, 2014 | {wlc{wa |
To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report
Credit Ratings of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
GSTIN Details of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Board of Directors and Signatories of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Board of Directors of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Here is the list of current board of directors of SPLENZ PHARMACEUTICALS PRIVATE LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Dec 31, 2015 | 10 Years 6 Months | |
Director | Current | Dec 31, 2015 | 10 Years 6 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Here is the list of current signatories of SPLENZ PHARMACEUTICALS PRIVATE LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Dec 31, 2015 | 10 Years 6 Months | |
Director | Current | Dec 31, 2015 | 10 Years 6 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Trademarks of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Patents of SPLENZ PHARMACEUTICALS PRIVATE LIMITED
FAQs about SPLENZ PHARMACEUTICALS PRIVATE LIMITED
Explore our recently published Legal Entities
